These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 31348638

  • 1. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT, Mészáros T, Vashegyi I, Fülöp T, Örfi E, Dézsi L, Rosivall L, Bavli Y, Urbanics R, Mollnes TE, Barenholz Y, Szebeni J.
    ACS Nano; 2019 Aug 27; 13(8):9315-9324. PubMed ID: 31348638
    [Abstract] [Full Text] [Related]

  • 2. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2018 Jun 27; 127():142-149. PubMed ID: 29462689
    [Abstract] [Full Text] [Related]

  • 3. Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies.
    Barta BA, Radovits T, Dobos AB, Tibor Kozma G, Mészáros T, Berényi P, Facskó R, Fülöp T, Merkely B, Szebeni J.
    Vaccine X; 2024 Aug 27; 19():100497. PubMed ID: 38933697
    [Abstract] [Full Text] [Related]

  • 4. Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells.
    Shimizu T, Mima Y, Hashimoto Y, Ukawa M, Ando H, Kiwada H, Ishida T.
    Immunobiology; 2015 Oct 27; 220(10):1151-60. PubMed ID: 26095176
    [Abstract] [Full Text] [Related]

  • 5. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
    Abu Lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H.
    Biol Pharm Bull; 2013 Oct 27; 36(11):1842-8. PubMed ID: 24189428
    [Abstract] [Full Text] [Related]

  • 6. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
    Dézsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, Őrfi E, Rosivall L, Nemes R, Kok RJ, Metselaar JM, Storm G, Szebeni J.
    J Control Release; 2014 Dec 10; 195():2-10. PubMed ID: 25148822
    [Abstract] [Full Text] [Related]

  • 7. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
    Hashimoto Y, Shimizu T, Mima Y, Abu Lila AS, Ishida T, Kiwada H.
    Toxicol Appl Pharmacol; 2014 May 15; 277(1):30-8. PubMed ID: 24632081
    [Abstract] [Full Text] [Related]

  • 8. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T, Ishida T, Kiwada H.
    Immunobiology; 2013 May 15; 218(5):725-32. PubMed ID: 22995937
    [Abstract] [Full Text] [Related]

  • 9. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
    Elsadek NE, Emam SE, Abu Lila AS, Shimizu T, Ando H, Ishima Y, Ishida T.
    Biol Pharm Bull; 2020 May 15; 43(9):1393-1397. PubMed ID: 32879214
    [Abstract] [Full Text] [Related]

  • 10. Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity.
    Mima Y, Abu Lila AS, Shimizu T, Ukawa M, Ando H, Kurata Y, Ishida T.
    J Control Release; 2017 Mar 28; 250():20-26. PubMed ID: 28179196
    [Abstract] [Full Text] [Related]

  • 11. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS, Kiwada H, Ishida T.
    J Control Release; 2013 Nov 28; 172(1):38-47. PubMed ID: 23933235
    [Abstract] [Full Text] [Related]

  • 12. Using Bio-Layer Interferometry to Evaluate Anti-PEG Antibody-Mediated Complement Activation.
    Mostafa M, Elsadek NE, Emam SE, Ando H, Shimizu T, Abdelkader H, Ishima Y, Aly UF, Sarhan HA, Ishida T.
    Biol Pharm Bull; 2022 Nov 28; 45(1):129-135. PubMed ID: 34980774
    [Abstract] [Full Text] [Related]

  • 13. Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
    Elsadek NE, Lila ASA, Emam SE, Shimizu T, Takata H, Ando H, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2020 Jul 28; 152():56-62. PubMed ID: 32376372
    [Abstract] [Full Text] [Related]

  • 14. A Maleimide-Terminally Modified PEGylated Liposome Induced the Accelerated Blood Clearance Independent of the Production of Anti-PEG IgM Antibodies.
    Ishima Y, Yamazaki N, Chuang VTG, Shimizu T, Ando H, Ishida T.
    Biol Pharm Bull; 2022 Jul 28; 45(10):1518-1524. PubMed ID: 36184510
    [Abstract] [Full Text] [Related]

  • 15. Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response.
    Shimizu T, Ichihara M, Yoshioka Y, Ishida T, Nakagawa S, Kiwada H.
    Biol Pharm Bull; 2012 Jul 28; 35(8):1336-42. PubMed ID: 22863934
    [Abstract] [Full Text] [Related]

  • 16. Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon.
    El Sayed MM, Takata H, Shimizu T, Kawaguchi Y, Abu Lila AS, Elsadek NE, Alaaeldin E, Ishima Y, Ando H, Kamal A, Sarhan HA, Ishida T.
    J Control Release; 2020 Jul 10; 323():102-109. PubMed ID: 32278827
    [Abstract] [Full Text] [Related]

  • 17. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y, Shimizu T, Abu Lila AS, Ishida T, Kiwada H.
    Biol Pharm Bull; 2015 Jul 10; 38(3):417-24. PubMed ID: 25757923
    [Abstract] [Full Text] [Related]

  • 18. Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.
    Szebeni J, Baranyi L, Savay S, Milosevits J, Bunger R, Laverman P, Metselaar JM, Storm G, Chanan-Khan A, Liebes L, Muggia FM, Cohen R, Barenholz Y, Alving CR.
    J Liposome Res; 2002 Jul 10; 12(1-2):165-72. PubMed ID: 12604051
    [Abstract] [Full Text] [Related]

  • 19. Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine.
    Shen L, Li Z, Ma A, Cruz-Teran C, Talkington A, Shipley ST, Lai SK.
    ACS Nano; 2024 Mar 26; 18(12):8733-8744. PubMed ID: 38469811
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive analysis of PEGylated liposome-associated proteins relating to the accelerated blood clearance phenomenon by combination with shotgun analysis and conventional methods.
    Kawanishi M, Hashimoto Y, Shimizu T, Sagawa I, Ishida T, Kiwada H.
    Biotechnol Appl Biochem; 2015 Mar 26; 62(4):547-55. PubMed ID: 25196743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.